Veru (VERU) Revenue & Revenue Breakdown
Veru Revenue Highlights
Latest Revenue (Y)
$16.89M
Latest Revenue (Q)
$3.95M
Main Geography (Y)
UNITED STATES
Veru Revenue by Period
Veru Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-09-30 | $16.89M | 3.62% |
2023-09-30 | $16.30M | -58.59% |
2022-09-30 | $39.35M | -35.76% |
2021-09-30 | $61.26M | 43.83% |
2020-09-30 | $42.59M | 33.92% |
2019-09-30 | $31.80M | 100.47% |
2018-09-30 | $15.86M | 16.18% |
2017-09-30 | $13.66M | -38.29% |
2016-09-30 | $22.13M | -32.13% |
2015-09-30 | $32.60M | 33.13% |
2014-09-30 | $24.49M | -22.15% |
2013-09-30 | $31.46M | -10.21% |
2012-09-30 | $35.03M | 88.71% |
2011-09-30 | $18.57M | -16.46% |
2010-09-30 | $22.22M | -19.32% |
2009-09-30 | $27.54M | 7.45% |
2008-09-30 | $25.63M | 32.68% |
2007-09-30 | $19.32M | 30.33% |
2006-09-30 | $14.82M | 32.82% |
2005-09-30 | $11.16M | 26.42% |
2004-09-30 | $8.83M | -2.39% |
2003-09-30 | $9.05M | 7.47% |
2002-09-30 | $8.42M | 25.32% |
2001-09-30 | $6.72M | 16.46% |
2000-09-30 | $5.77M | 22.30% |
1999-09-30 | $4.72M | -13.50% |
1998-09-30 | $5.45M | 86.92% |
1997-09-30 | $2.92M | 41.28% |
1996-09-30 | $2.06M | -6.17% |
1995-09-30 | $2.20M | -86.42% |
1994-09-30 | $16.20M | 29.60% |
1993-09-30 | $12.50M | - |
Veru Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $3.95M | -4.39% |
2024-03-31 | $4.14M | 93.17% |
2023-12-31 | $2.14M | -44.57% |
2023-09-30 | $3.86M | 15.59% |
2023-06-30 | $3.34M | -49.27% |
2023-03-31 | $6.59M | 162.62% |
2022-12-31 | $2.51M | -3.12% |
2022-09-30 | $2.59M | -73.04% |
2022-06-30 | $9.60M | -26.30% |
2022-03-31 | $13.03M | -7.83% |
2021-12-31 | $14.14M | -9.66% |
2021-09-30 | $15.65M | -11.38% |
2021-06-30 | $17.66M | 32.35% |
2021-03-31 | $13.34M | -8.73% |
2020-12-31 | $14.62M | 24.41% |
2020-09-30 | $11.75M | 13.83% |
2020-06-30 | $10.32M | 3.81% |
2020-03-31 | $9.94M | -6.00% |
2019-12-31 | $10.58M | 21.19% |
2019-09-30 | $8.73M | -10.27% |
2019-06-30 | $9.73M | 39.43% |
2019-03-31 | $6.98M | 9.48% |
2018-12-31 | $6.37M | 22.46% |
2018-09-30 | $5.20M | -5.42% |
2018-06-30 | $5.50M | 113.84% |
2018-03-31 | $2.57M | -0.53% |
2017-12-31 | $2.59M | -29.95% |
2017-09-30 | $3.69M | -14.41% |
2017-06-30 | $4.31M | 79.34% |
2017-03-31 | $2.41M | -25.84% |
2016-12-31 | $3.24M | -8.97% |
2016-09-30 | $3.56M | -35.92% |
2016-06-30 | $5.56M | 16.51% |
2016-03-31 | $4.77M | -42.01% |
2015-12-31 | $8.23M | 15.03% |
2015-09-30 | $7.15M | -8.42% |
2015-06-30 | $7.81M | -28.83% |
2015-03-31 | $10.98M | 64.85% |
2014-12-31 | $6.66M | 19.90% |
2014-09-30 | $5.55M | -29.70% |
2014-06-30 | $7.90M | 81.77% |
2014-03-31 | $4.35M | -35.04% |
2013-12-31 | $6.69M | 39.69% |
2013-09-30 | $4.79M | -34.22% |
2013-06-30 | $7.28M | -23.18% |
2013-03-31 | $9.48M | -4.37% |
2012-12-31 | $9.91M | -0.01% |
2012-09-30 | $9.91M | 14.50% |
2012-06-30 | $8.66M | 10.53% |
2012-03-31 | $7.83M | -9.30% |
2011-12-31 | $8.63M | 21.46% |
2011-09-30 | $7.11M | 102.11% |
2011-06-30 | $3.52M | -17.96% |
2011-03-31 | $4.29M | 17.41% |
2010-12-31 | $3.65M | -53.19% |
2010-09-30 | $7.80M | 344.64% |
2010-06-30 | $1.75M | -75.57% |
2010-03-31 | $7.18M | 30.80% |
2009-12-31 | $5.49M | -30.63% |
2009-09-30 | $7.91M | 13.57% |
2009-06-30 | $6.97M | -4.82% |
2009-03-31 | $7.32M | 36.95% |
2008-12-31 | $5.34M | -31.83% |
2008-09-30 | $7.84M | 38.56% |
2008-06-30 | $5.66M | -11.61% |
2008-03-31 | $6.40M | - |
Veru Revenue Breakdown
Veru Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Sep 24 | Sep 23 | Sep 22 | Sep 21 | Sep 20 |
---|---|---|---|---|---|
Product and Service, Other | - | - | - | - | - |
Other Products | - | $13.01K | $2.42K | - | - |
Preboost Segment | - | - | - | $862.83K | $2.04M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 23 | Jun 23 | Mar 23 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | Mar 18 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Products | $7.72K | $-225.00 | $5.52K | - | - | - | - | - | - | - | - | - | - |
Preboost Segment | - | - | - | $862.83K | $785.28K | $676.03K | $420.83K | $153.09K | $261.09K | $443.32K | - | - | - |
Z | - | - | - | - | - | - | - | - | - | - | $24.00K | $372.00K | $378.00K |
M | - | - | - | - | - | - | - | - | - | - | - | $127.00K | - |
Other Countries | - | - | - | - | - | - | - | - | - | - | - | $2.57M | $221.00K |
U | - | - | - | - | - | - | - | - | - | - | - | $641.00K | $981.00K |
Latest
Veru Revenue Breakdown by Country
Annual Revenue by Country
Country | Sep 24 | Sep 22 | Sep 21 | Sep 20 | Sep 19 |
---|---|---|---|---|---|
MOZAMBIQUE | $2.17M | - | - | - | - |
UNITED STATES | $5.35M | - | - | - | - |
SOUTH AFRICA | $1.90M | - | - | - | - |
BRAZIL | $2.76M | - | - | - | - |
Other Geographical Areas | $4.70M | - | - | - | - |
Other Countries | - | $7.92M | $12.32M | $12.25M | $14.54M |
U | - | $31.43M | $48.94M | $30.34M | $17.26M |
Latest
Quarterly Revenue by Country
Country | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Countries | $865.11K | $784.64K | $1.28M | $470.31K | $1.44M | $1.94M | $2.58M | $1.18M | $2.23M | $1.76M | $3.57M | $2.73M | $4.26M | $1.99M | $2.74M | $2.27M | $2.48M | $5.76M | $3.31M | $1.99M |
U | - | - | $1.45M | $4.79M | $257.47K | $649.96K | $7.02M | $11.85M | $11.91M | $13.89M | $14.08M | $10.61M | $10.36M | $9.76M | $6.40M | $7.67M | $6.49M | $2.60M | - | - |
Z | - | - | $612.00K | $1.33M | $1.18M | $610.00K | $590.00K | - | - | - | - | - | - | - | - | - | - | - | - | - |
North America | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $5.55M | - |
Latest
Veru Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
SRPT | Sarepta Therapeutics | $1.24B | $362.93M |
NVAX | Novavax | $983.71M | $415.48M |
AXSM | Axsome Therapeutics | $270.60M | $87.17M |
PBYI | Puma Bio | $235.64M | $56.14M |
MCRB | Seres Therapeutics | $126.33M | - |
TSVT | 2seventy bio | $100.39M | $13.53M |
VERU | Veru | $16.89M | $3.95M |
LXRX | Lexicon Pharmaceuticals | $1.20M | $1.74M |
IOVA | Iovance Biotherapeutics | $1.19M | $58.55M |
ANVS | Annovis Bio | - | - |
AVXL | Anavex Life Sciences | - | - |